Bikanta careers

Early detection of cancer, & its deadly metastasis, is necessary for increasing the cure rate. Current cancer screening is unable to detect breakaway tumor cells that lead to micrometastatic tumors. Bikanta is introducing a revolutionary nanotechnology platform based on nanodiamonds that empowers researchers & medics to detect & address diseases early at the molecular level.

Nanodiamonds are next generation imaging probes trailblazing cutting-edge research including applications with the recent Nobel Prize in Chemistry for super-resolved fluorescence microscopy & utility in cancer detection devices complementary to Google X's research (goo.gl/HYPsDN), Bikanta's technologies are positioned for significant market penetration into $40-60B R&D markets before large clinical follow-on markets.